Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies
Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies is a paper indexed in PICO Portal from OpenAlex.
How many citations does Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies have?
Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies has 15 citations in the OpenAlex counts PICO Portal stores.
When was Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies published?
Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies has 1998 year in the PICO Portal index.
What is the open-access status of Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies?
Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies has closed oa status in the PICO Portal index.
What is the DOI of Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies?
The DOI for Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies is on the source record.
What is the PMID of Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies?
The PMID for Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies is on the source record.
What is the OpenAlex record for Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies?
The OpenAlex for Reduced fetal exposure to aspirin using a novel controlled‐release preparation in normotensive and hypertensive pregnancies is on the source record.